Terumo Medical Corporation

Terumo Medical Corporation Overview

Company Headquarters: Tokyo, Japan

Founded: 1921

Workforce: 25,000

Company Working: Terumo Medical Corporation delivers innovative health solutions and provides breakthrough solutions and technologies. The company is involved in manufacturing and sales of medical products and equipment, such as pharmaceuticals, nutritional food supplements, disposable medical devices, vascular grafts, and blood glucose monitoring systems, among others. It has a market presence in over 160 countries in the world. It operates its business through three segments, namely, cardiac and vascular company, blood management company, and general hospital company. Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies. TIS offers a complete, solution-based product portfolio used in advanced coronary, peripheral endovascular and urological treatments with strategic initiatives in Transradial Access, Complex Coronary Intervention, Peripheral Artery Disease and Embolotherapy.

Strategy

Terumo Medical Corporation focuses on developing technologically advanced products. The company aims to maintain and enhance customer satisfaction by providing quality products and improving customer support and services. Moreover, with ongoing and past acquisitions, it aims to acquire a high level of expertise and organizational capabilities to engage in mergers and acquisitions outside Japan. Also, in current years, the company is focused on increasing the production capacity of its products in the TIS division. For instance, the company is progressively investing to increase its production capacity for intervention products at the Vietnam factory to respond to growing demand in countries, such as China and India.

Company Snapshot

$4,210M

Revenue

25,000

Employees

1921

Founded

Tokyo, Japan

Headquarters

SWOT Analysis

Strengths

Strong Management
Strong supply chain
Brand Name
Strong brand value
Strong R&D capabilities
Global market presence
Strong global presence
State-of-the-art manufacturing facilities
Partnerships with hospitals and other regional vendors

Weaknesses

Weak online presence
Work in competencies
Environment safety issues
Product recalls
Various safety notices given to the company by regulatory authorities

Opportunities

Online market
Acquisition
Financial leverage
Innovations in product development and product technology
Expansion with the help of strategic acquisitions
Expansion opportunities in low economies
Expansion of product lines

Threats

Volatile revenue
Stable Pricing
Government regulatory policies
Fluctuations in currency exchange
Stringent regulatory policies
High competition from existing market giants

Key Developments

Date	Approach	Development
September 2016	Acquisition	Terumo Corp looks to purchase portion of Abbott Laboratories' medical device
June 2016	Acquisition	Terumo's unit to purchase all shares of Sequent Medical
January 2019	Expansion	Terumo Medical Corporation announced the opening of a 58,000 square foot facility in Ontario. This move strengthens the company’s expansion into the Canadian market.
January 2018	Expansion	Terumo Medical Corporation integrated the Silicon Valley Lab research and development facilities in northern California, US, with, Kalila Medical, Inc., one of its subsidiaries. The company moved both facilities to a new site, named Terumo Bay Area Innovation Lab. Over the next five years, the company plans to employ up to 50 people, about twice the current number.
July 2016	Acquisition	The company completed the acquisition of Sequent Medical, Inc., a privately-held medical device firm based in California, US with European operations based in Bonn, Germany.

Product Offering

Terumo Medical Corporation
- Balloon Dilatation Catheter
- Stent
- Embolics
- Safety Lancets

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.